8-Bromo-3-methylimidazo[1,2-a]pyridine-2-carboxylic acid, 1g

5-Cyano-6-methylnicotinic acid, 98%, 500mg

Fmoc-Val-Cit-PAB-OH>98.0%(HPLC)25mg

(4-Chloro-3-fluoropyridin-2-yl)methanamine, 98%, 5g

Oxazole, 2-[2-(diphenylphosphino)phenyl]-4,5-dihydro-4-(1-methylethyl)-, (4S)-, 98%, 1g

2-Ethoxyethanol, 99% min, for synthesis, 1L, glass packaging

(2-Fluoro-3-methylpyridin-4-yl)boronic acid, 95%, 250mg

N-(2,2,2-trifluoroethyl)aniline, 95.0%, 500mg

(R)-tert-Butyl 2-(1,3-dioxoisoindolin-2-yloxy)-3-phenylpropanoate, 98%, 1g

Ethyl 4-chloro-2-hydroxybenzoate, 1g

8-Bromo-1-naphthaldehyde, 97%, 100mg

2-Amino-5-chlorophenol, 95.0%, 1g

(S)-2-(3-(Pyridin-2-ylmethoxy)pyrrolidin-1-yl)-5-(trifluoromethyl)benzoic acid, 98%, 1g